Feb 9, 2026 • 9:53 AM EST XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
Dec 30, 2025 • 7:30 AM EST XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
